Literature DB >> 19097920

Juvenile galactosialidosis with attacks of neuropathic pain and absence of sialyloligosacchariduria.

Niklas Darin1, Mårten Kyllerman, Anna-Lena Hård, Claes Nordborg, Jan-Eric Månsson.   

Abstract

Galactosialidosis (MIM 256540) is an autosomal recessive lysosomal storage disease caused by a defect of the protective protein/cathepsin A. Increased amounts of urinary sialic acid-rich oligosaccharides are considered to be an essential diagnostic marker of the disease. We here report a patient with atypical clinical features who consistently has excreted normal amounts of sialyloligosaccharides in the urine. The boy started to have attacks of neuropathic pain associated with hyperesthesia around 1(1/2) years of age. From 4 years of age when his vision was first tested, the patient developed progressive visual loss and at the age of 10 years, macular cherry-red spots were found. At this age, he also had a mild learning disability and clinical examination showed mild facial coarsening, increased lumbar lordosis and pyramidal signs in the legs. In conclusion, the clinical and laboratory features of this patient show that galactosialidosis may be considered in patients even in the absence of oligosacchariduria and that galactosialidosis should be regarded as a differential diagnosis in patients with neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19097920     DOI: 10.1016/j.ejpn.2008.11.003

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  4 in total

1.  A Turkish case of galactosialidosis with a new homozygous mutation in CTSA gene.

Authors:  Ayşe Kartal; Kürşad Aydın
Journal:  Metab Brain Dis       Date:  2017-05-30       Impact factor: 3.584

2.  Galactosialidosis: historic aspects and overview of investigated and emerging treatment options.

Authors:  Ida Annunziata; Alessandra d'Azzo
Journal:  Expert Opin Orphan Drugs       Date:  2016-12-14       Impact factor: 0.694

Review 3.  Role of Gangliosides in Peripheral Pain Mechanisms.

Authors:  Péter Sántha; Ildikó Dobos; Gyöngyi Kis; Gábor Jancsó
Journal:  Int J Mol Sci       Date:  2020-02-03       Impact factor: 5.923

Review 4.  Galactosialidosis: review and analysis of CTSA gene mutations.

Authors:  Anna Caciotti; Serena Catarzi; Rodolfo Tonin; Licia Lugli; Carmen Rodriguez Perez; Helen Michelakakis; Irene Mavridou; Maria Alice Donati; Renzo Guerrini; Alessandra d'Azzo; Amelia Morrone
Journal:  Orphanet J Rare Dis       Date:  2013-08-02       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.